At a glance
- Originator Aventis
- Class Antihypertensives; Vasodilators
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Ischaemic heart disorders
Most Recent Events
- 01 Feb 2002 Discontinued-preclinical for Ischaemic heart disorders
- 01 Feb 2002 Discontinued-unspecified phase for Heart Failure